Pharmacotherapy of depression in palliative patients

Pharmacotherapy of depression in palliative patients

Show other versions (1)

Introduction: Depression often affects people suffering from serious illnesses, including oncological and palliative patients. It reduces their quality of life and worsens their prognosis. This is why it is so important to properly treat depression in palliative patients. Material and Methods: Th...

Full description

Bibliographic Details
Main Authors:	Paulina Trawka, Aleksandra Paszkowska, Magdalena Lamch, Aleksandra Wijata, Paweł Hejnosz, Karolina Graczykowska, Magdalena Julia Jabłońska, Jakub Dorobiała, Maciej Lazarek, Michał Denkiewicz, Kornelia Kędziora-Kornatowska
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2019-08-01
Series:	Journal of Education, Health and Sport
Subjects:	depression palliative patients sluggish serotonin reuptake inhibitors ssri tricyclic antidepressants tca
Online Access:	http://www.ojs.ukw.edu.pl/index.php/johs/article/view/7293

Similar Items

Pharmacotherapy of depression in palliative patients
by: Paulina Trawka, et al.
Published: (2019-08-01)

Antidepressants and cardiovascular adverse events: A narrative review
by: Mohammad Hassan Nezafati, et al.
Published: (2015-09-01)

Antidepressants with antimicrobial activity? A promising therapeutic strategy
by: Gloria M. González, et al.
Published: (2022-07-01)

Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function.
by: Nathan C Mitchell, et al.
Published: (2013-10-01)

Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies
by: Lisa Nicolai, et al.
Published: (2023-01-01)

Sexual dysfunction in married female patients on antidepressants: A Cross Sectional Observational study from Patna medical college and hospital
by: Vivek Pratap Singh, et al.
Published: (2021-10-01)

Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients
by: Orestes Vicente Forlenza, et al.
Published: (2000-07-01)

Focus on the use of antidepressants to treat pediatric functional abdominal pain: current perspectives
by: Bonilla S, et al.
Published: (2018-09-01)

Trends in Antidepressant Use and Expenditure in Six Major Cities in China From 2013 to 2018
by: Zhenwei Yu, et al.
Published: (2020-07-01)

The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
by: Dena Firouzabadi, et al.
Published: (2022-11-01)

Doxepin Has a Potent and Long-Acting Spinal Anesthetic Effect in Rats
by: Bor-Chin Cheng, et al.
Published: (2006-02-01)

Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review
by: Sun Jung Oh, et al.
Published: (2020-09-01)

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis
by: Juntao Yin, et al.
Published: (2023-11-01)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
by: Stefania Chiappini, et al.
Published: (2022-05-01)

Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study
by: Mette Bliddal, et al.
Published: (2023-06-01)

Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis
by: Renato de Filippis, et al.
Published: (2022-04-01)

The Association Between Prenatal Exposure to Antidepressants and Autism: Some Research and Public Health Aspects
by: Ori Kapra, et al.
Published: (2020-11-01)

TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli
by: Jin Ou, et al.
Published: (2022-12-01)

Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
by: Hui Wen, et al.
Published: (2019-01-01)

Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
by: Joseph Ben-Sheetrit, et al.
Published: (2023-04-01)

The pathophysiology of Post SSRI Sexual Dysfunction – Lessons from a case study
by: Samantha Klaas, et al.
Published: (2023-05-01)

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
by: Bruno P. Guiard, et al.
Published: (2011-01-01)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
by: Stacey L. Aldrich, et al.
Published: (2019-02-01)

Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
by: Eliasz Panek, et al.
Published: (2023-04-01)

Depression and Psychological Distress as Risk Factors for Stroke and Worse Stroke Recovery: Clinical Implications and Therapeutic Options
by: Kerstin Sander, et al.
Published: (2014-07-01)

Effect of Depression and Antidepressants on Sexual Dysfunction in Men with Diabetes: A National Population-Based Cohort Study
by: Chung PL, et al.
Published: (2020-04-01)

Are Noradrenergic Transmission Reducing Drugs Antidepressants?
by: Paul J. Fitzgerald
Published: (2021-09-01)

Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice
by: Pranav Sikka, et al.
Published: (2011-01-01)

Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
by: Xin KZ, et al.
Published: (2019-08-01)

Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden
by: Erik Lundström, et al.
Published: (2020-02-01)

A comparative study of personality aspects of females with depression using the antidepressant medications: selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
by: Saeed Pournaghash tehrani, et al.
Published: (2018-03-01)

Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?
by: Zesheng Li, et al.
Published: (2023-05-01)

Prenatal selective serotonin reuptake inhibitor (SSRI) exposure induces working memory and social recognition deficits by disrupting inhibitory synaptic networks in male mice
by: Weonjin Yu, et al.
Published: (2019-04-01)

The Role of Selective Serotonin Reuptake Inhibitors in Premature Ejaculation
by: Alka Aggarwal, et al.
Published: (2017-08-01)

Seizure reduction with fluoxetine in an adult woman with Dravet syndrome
by: Kimford J. Meador
Published: (2014-01-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
by: Thibault eRenoir
Published: (2013-04-01)

Too Much and Too Little: Antidepressant Treatment in Stroke Survivors during the First Year
by: Katja Werheid, et al.
Published: (2022-06-01)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
by: Najmeh Shahini, et al.
Published: (2021-07-01)

Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
by: Thomas Blom, et al.
Published: (2020-07-01)

Learning from Negative Feedback in Patients with Major Depressive Disorder is Attenuated by SSRI Antidepressants
by: Mohammad M. Herzallah, et al.
Published: (2013-09-01)